ODYY
Odyssey Health, Inc.
Price Chart
Latest Quote
$0.02
+0.01 (+54.55%)
Current Price
| Previous Close | $0.01 |
| Open | $0.01 |
| Day High | $0.02 |
| Day Low | $0.01 |
| Volume | 270,674 |
Stock Information
| Shares Outstanding | 100.97M |
| Total Debt | $2.64M |
| Cash Equivalents | $298K |
| Net Income | $-3.57M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $1.72M |
| EPS (TTM) | $-0.04 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.05M |
| Income | $-3.57M |
| Book/sh | $-0.11 |
| Cash/sh | $0.00 |
| Employees | 2 |
Financial Ratios
| Quick Ratio | 0.03 |
| Current Ratio | 0.04 |
Returns & Margins
| ROA | -217.91% |
Ownership
| Insider Ownership | 15.69% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | -0.16 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.01 |
| SMA50 | $0.04 |
| SMA200 | $0.05 |
| RSI | 47.83 |
| ATR | 0.0026 |
| Shares Float | 85.13M |
| Volatility | -1.58 |
| Rel Volume | 1.97 |
Performance History
| Week | +183.33% |
| Month | -19.05% |
| Quarter | -71.67% |
| 6 Months | -48.48% |
| YTD | -48.48% |
| Year | +13.33% |
| 3 Years | -77.63% |
| 5 Years | -97.42% |
| 10 Years | -93.82% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.02 | 646,500 |
| 2026-06-17 | $0.01 | 12,600 |
| 2026-06-16 | $0.01 | 313,100 |
| 2026-06-15 | $0.01 | 15,300 |
| 2026-06-12 | $0.01 | 92,500 |
| 2026-06-11 | $0.01 | 16,600 |
| 2026-06-10 | $0.01 | 2,927,000 |
| 2026-06-09 | $0.01 | 74,600 |
| 2026-06-08 | $0.01 | 1,900,900 |
| 2026-06-05 | $0.01 | 55,100 |
| 2026-06-04 | $0.01 | 67,700 |
| 2026-06-03 | $0.01 | 96,700 |
| 2026-06-02 | $0.01 | 9,000 |
| 2026-06-01 | $0.02 | 6,200 |
| 2026-05-29 | $0.02 | 14,600 |
| 2026-05-28 | $0.02 | 4,000 |
| 2026-05-27 | $0.02 | 57,600 |
| 2026-05-26 | $0.02 | 102,400 |
| 2026-05-22 | $0.02 | 1,400 |
| 2026-05-21 | $0.02 | 160,900 |
| 2026-05-20 | $0.02 | 300 |
| 2026-05-19 | $0.02 | 70,100 |
About Odyssey Health, Inc.
Odyssey Health, Inc., a medical company, focuses on the development and acquisition of medical products and health related technologies. The company develops CardioMap, a heart monitoring and screening device; and Save A Life choking rescue devices. Its product candidates include ONP-002 for the treatment of mild brain trauma or concussion. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was incorporated in 2014 and is based in Las Vegas, Nevada.
đ° Latest News
No news articles available at the moment. Check back later for updates on ODYY.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | - | $0 | $0 | $0 |
| Operating Revenue | - | $0 | $0 | $0 |
| Reconciled Cost Of Revenue | - | - | - | - |
| Cost Of Revenue | - | - | - | - |
| Expenses | ||||
| Interest Expense | - | $518,476 | $614,083 | $836,294 |
| Total Expenses | - | $2,139,612 | $5,144,015 | $8,106,580 |
| Other Income Expense | - | $1,815,772 | $-161,323 | $498,743 |
| Other Non Operating Income Expenses | - | $9,265 | $8,677 | $498,743 |
| Net Non Operating Interest Income Expense | - | $-518,476 | $-614,083 | $-836,294 |
| Interest Expense Non Operating | - | $518,476 | $614,083 | $836,294 |
| Operating Expense | - | $2,139,612 | $5,144,015 | $8,106,580 |
| General And Administrative Expense | - | $2,084,446 | $4,942,686 | $6,789,556 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | - | $-842,316 | $-5,919,421 | $-8,444,131 |
| Net Interest Income | - | $-518,476 | $-614,083 | $-836,294 |
| Normalized Income | - | $-2,648,823 | $-5,749,421 | $-8,444,131 |
| Net Income From Continuing And Discontinued Operation | - | $-842,316 | $-5,919,421 | $-8,444,131 |
| Total Operating Income As Reported | - | $-2,139,612 | $-5,314,015 | $-8,106,580 |
| Net Income Common Stockholders | - | $-905,771 | $-5,919,421 | $-8,444,131 |
| Net Income | - | $-842,316 | $-5,919,421 | $-8,444,131 |
| Net Income Including Noncontrolling Interests | - | $-842,316 | $-5,919,421 | $-8,444,131 |
| Net Income Continuous Operations | - | $-842,316 | $-5,919,421 | $-8,444,131 |
| Pretax Income | - | $-842,316 | $-5,919,421 | $-8,444,131 |
| Special Income Charges | - | $3,445,250 | $-170,000 | $0 |
| Operating Income | - | $-2,139,612 | $-5,144,015 | $-8,106,580 |
| Gross Profit | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $-0.02 | $-0.01 | $-0.07 | $-0.09 |
| Basic EPS | $-0.02 | $-0.01 | $-0.07 | $-0.09 |
| Other | ||||
| Diluted Average Shares | $104,709,763 | $97,064,040 | $82,677,354 | $88,995,280 |
| Basic Average Shares | $104,709,763 | $97,064,040 | $82,677,354 | $88,995,280 |
| Tax Effect Of Unusual Items | - | $0 | $0 | $0 |
| Tax Rate For Calcs | - | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | - | $-2,128,809 | $-5,131,922 | $-7,605,463 |
| Total Unusual Items | - | $1,806,507 | $-170,000 | $0 |
| Total Unusual Items Excluding Goodwill | - | $1,806,507 | $-170,000 | $0 |
| Reconciled Depreciation | - | $1,538 | $3,416 | $2,374 |
| EBITDA (Bullshit earnings) | - | $-322,302 | $-5,301,922 | $-7,605,463 |
| EBIT | - | $-323,840 | $-5,305,338 | $-7,607,837 |
| Diluted NI Availto Com Stockholders | - | $-905,771 | $-5,919,421 | $-8,444,131 |
| Otherunder Preferred Stock Dividend | - | $63,455 | $0 | - |
| Gain On Sale Of Ppe | - | $16,400,687 | $0 | - |
| Write Off | - | $12,955,437 | $0 | - |
| Gain On Sale Of Security | - | $-1,638,743 | - | - |
| Research And Development | - | $55,166 | $201,329 | $1,317,024 |
| Selling General And Administration | - | $2,084,446 | $4,942,686 | $6,789,556 |
| Other Gand A | - | $2,084,446 | $2,122,375 | $2,919,091 |
| Salaries And Wages | - | $577,805 | $2,820,311 | $3,870,465 |
| Other Special Charges | - | - | $170,000 | - |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-5,333,749 | $-6,205,834 | $-4,686,877 | $-2,767,354 |
| Total Assets | $586,146 | $455,793 | $569,677 | $610,533 |
| Total Non Current Assets | $529,203 | $49,905 | $43,260 | $414 |
| Goodwill And Other Intangible Assets | $0 | $49,905 | $43,260 | $0 |
| Current Assets | $56,943 | $405,888 | $526,417 | $610,119 |
| Other Current Assets | $54,564 | $369,023 | $453,883 | - |
| Cash Cash Equivalents And Short Term Investments | $2,379 | $36,865 | $72,534 | $556,584 |
| Cash And Cash Equivalents | $2,379 | $36,865 | $72,534 | $556,584 |
| Cash Financial | $2,379 | $36,865 | $72,534 | $556,584 |
| Prepaid Assets | - | - | $453,883 | $53,535 |
| Debt | ||||
| Net Debt | $1,644,154 | $2,107,795 | $1,459,403 | $179,656 |
| Total Debt | $1,646,533 | $2,144,660 | $1,531,937 | $736,240 |
| Current Debt And Capital Lease Obligation | $1,646,533 | $2,144,660 | $1,531,937 | $736,240 |
| Current Debt | $1,646,533 | $2,144,660 | $1,531,937 | $736,240 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $5,919,895 | $6,611,722 | $5,213,294 | $3,377,887 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $0 |
| Current Liabilities | $5,919,895 | $6,611,722 | $5,213,294 | $3,377,887 |
| Other Current Liabilities | $1,125,026 | $1,125,026 | $1,125,026 | $1,125,026 |
| Current Notes Payable | $1,646,533 | $2,144,660 | $1,531,937 | $736,240 |
| Payables And Accrued Expenses | $3,148,336 | $3,342,036 | $2,556,331 | $1,516,621 |
| Interest Payable | $223,754 | $142,032 | $110,063 | $32,351 |
| Payables | $2,924,582 | $1,797,656 | $1,549,568 | $1,224,783 |
| Accounts Payable | $2,924,582 | $1,797,656 | $1,549,568 | $1,224,783 |
| Equity | ||||
| Common Stock Equity | $-5,333,749 | $-6,155,929 | $-4,643,617 | $-2,767,354 |
| Total Equity Gross Minority Interest | $-5,333,749 | $-6,155,929 | $-4,643,617 | $-2,767,354 |
| Stockholders Equity | $-5,333,749 | $-6,155,929 | $-4,643,617 | $-2,767,354 |
| Retained Earnings | $-61,003,146 | $-60,097,375 | $-54,177,954 | $-45,733,823 |
| Other | ||||
| Ordinary Shares Number | $96,709,763 | $79,067,879 | $77,860,563 | $87,191,168 |
| Share Issued | $96,709,763 | $79,067,879 | $77,860,563 | $87,191,168 |
| Tangible Book Value | $-5,333,749 | $-6,205,834 | $-4,686,877 | $-2,767,354 |
| Invested Capital | $-3,687,216 | $-4,011,269 | $-3,111,680 | $-2,031,114 |
| Working Capital | $-5,862,952 | $-6,205,834 | $-4,686,877 | $-2,767,768 |
| Total Capitalization | $-5,333,749 | $-6,155,929 | $-4,643,617 | $-2,767,354 |
| Additional Paid In Capital | $55,572,687 | $53,862,378 | $49,456,476 | $42,879,278 |
| Capital Stock | $96,710 | $79,068 | $77,861 | $87,191 |
| Common Stock | $96,710 | $79,068 | $77,861 | $87,191 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Current Accrued Expenses | $223,754 | $1,544,380 | $1,006,763 | $291,838 |
| Investments And Advances | $529,203 | $0 | - | - |
| Net PPE | - | - | $0 | $414 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-1,215,210 | $-1,484,757 | $-3,221,003 | $-3,423,111 |
| Operating Activities | ||||
| Operating Cash Flow | $-1,215,210 | $-1,474,696 | $-3,175,783 | $-3,423,111 |
| Cash Flow From Continuing Operating Activities | $-1,215,210 | $-1,474,696 | $-3,175,783 | $-3,423,111 |
| Operating Gains Losses | $-16,400,687 | $532,434 | $687,429 | $858,942 |
| Investing Activities | ||||
| Investing Cash Flow | $1,000,000 | $-10,061 | $-45,220 | $0 |
| Cash Flow From Continuing Investing Activities | $1,000,000 | $-10,061 | $-45,220 | $0 |
| Net Other Investing Changes | $1,000,000 | - | - | - |
| Capital Expenditure | - | $-10,061 | $-45,220 | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $55,620 | $580,220 | $2,469,222 | $2,935,975 |
| Financing Cash Flow | $180,724 | $1,449,088 | $2,736,953 | $3,916,743 |
| Cash Flow From Continuing Financing Activities | $180,724 | $1,449,088 | $2,736,953 | $3,916,743 |
| Net Common Stock Issuance | $55,620 | $580,220 | $2,469,222 | $2,935,975 |
| Common Stock Issuance | $55,620 | $580,220 | $2,469,222 | $2,935,975 |
| Net Other Financing Charges | - | - | - | $-169,000 |
| Other | ||||
| Repayment Of Debt | $-274,896 | $-35,000 | $-107,269 | $-415,232 |
| Issuance Of Debt | $400,000 | $903,868 | $375,000 | $1,565,000 |
| Interest Paid Supplemental Data | $37,376 | $3,431 | $954 | $34,345 |
| End Cash Position | $2,379 | $36,865 | $72,534 | $556,584 |
| Beginning Cash Position | $36,865 | $72,534 | $556,584 | $62,952 |
| Changes In Cash | $-34,486 | $-35,669 | $-484,050 | $493,632 |
| Net Issuance Payments Of Debt | $125,104 | $868,868 | $267,731 | $1,149,768 |
| Net Short Term Debt Issuance | $125,104 | $868,868 | $267,731 | $1,149,768 |
| Short Term Debt Payments | $-274,896 | $-35,000 | $-107,269 | $-415,232 |
| Short Term Debt Issuance | $400,000 | $903,868 | $375,000 | $1,565,000 |
| Net Intangibles Purchase And Sale | $0 | $-10,061 | $-45,220 | $0 |
| Purchase Of Intangibles | $0 | $-10,061 | $-45,220 | - |
| Change In Working Capital | $514,866 | $916,814 | $639,362 | $2,210,297 |
| Change In Payables And Accrued Expense | $200,407 | $831,954 | $1,039,710 | $1,102,140 |
| Change In Accrued Expense | $396,395 | $583,867 | $714,925 | $101,744 |
| Change In Interest Payable | $150,157 | $78,219 | $77,712 | $53,959 |
| Change In Payable | $-195,988 | $248,087 | $324,785 | $1,000,396 |
| Change In Account Payable | $-195,988 | $248,087 | $324,785 | $1,000,396 |
| Change In Prepaid Assets | $60,518 | $-5,048 | $-33,873 | $-16,869 |
| Change In Receivables | $253,941 | $89,908 | $-366,475 | - |
| Other Non Cash Items | $339,404 | $2,992,061 | $3,939,183 | $10,385,193 |
| Unrealized Gain Loss On Investment Securities | $1,638,743 | $0 | - | - |
| Asset Impairment Charge | $12,955,437 | $0 | - | - |
| Depreciation Amortization Depletion | $1,538 | $3,416 | $2,374 | $5,552 |
| Depreciation And Amortization | $1,538 | $3,416 | $2,374 | $5,552 |
| Amortization Cash Flow | $1,538 | $3,416 | $2,374 | - |
| Amortization Of Intangibles | $1,538 | $3,416 | $2,374 | - |
| Gain Loss On Investment Securities | $330,654 | $532,434 | $687,429 | $858,942 |
| Net Income From Continuing Operations | $-842,316 | $-5,919,421 | $-8,444,131 | $-16,883,095 |
| Change In Other Current Liabilities | - | - | $0 | $1,125,026 |
| Net Long Term Debt Issuance | - | - | - | $1,149,768 |
| Long Term Debt Payments | - | - | - | $-415,232 |
| Long Term Debt Issuance | - | - | - | $1,565,000 |
| Stock Based Compensation | - | - | - | $2,006,193 |
Fetched: 2026-02-02